Far upstream element-binding protein-1 (FBP-1) binds to an upstream element of the c-myc promoter and regulates the c-myc mRNA level. Earlier, FBP-1 was identified as a candidate substrate of caspase-7. Here, we report that FBP-1 is cleaved by executor caspases, both in vitro and during apoptosis. Cleavage occurs at the caspase consensus site (DQPD 74 ) located within the classical bipartite nuclear localization signal sequence. In cells subjected to apoptotic stimuli, the caspase-mediated cleavage of FBP-1 leads to its decreased presence in the nucleus, concomitant with the marked downregulation of c-Myc and its various target proteins. By contrast, cells transfected with a non-cleavable mutant of FBP-1 (D74A) maintain higher levels of c-Myc and are protected from apoptosis. On the basis of these results, we suggest that the oncogenic potential of c-Myc is 'switched off' after apoptosis induction as a consequence of the caspasemediated cleavage of FBP-1.
Introduction
The c-myc proto-oncogene encodes an important member of the basic helix-loop-helix leucine zipper family of transcription factors and is involved in cell growth, proliferation, differentiation and apoptosis (Blackwood and Eisenman, 1991; Chung and Levens, 2005) . Dysregulation of c-myc induces cellular transformation in vitro and tumorigenesis in vivo (Pelengaris et al., 2002) . In general, low levels of c-myc mRNA and protein are expressed in normally proliferating cells. However, even slight fluctuations in these amounts have dramatic consequences on cell fate. Therefore, c-myc evidently requires tight control and represents a promising target of anticancer therapy (Liu et al., 2007; Wierstra and Alves, 2008) .
Expressional regulation of c-myc occurs mainly at the transcriptional level. To date, about 50 types of specific factors that regulate c-myc transcription have been identified. Among these, FBPs (Far Upstream ElementBinding Proteins) modulate c-Myc expression by binding to a single-stranded far upstream element (FUSE) located upstream of the c-myc promoter. Three FBP family members exist in humans. A large common set of genes is cross-regulated by FBP proteins. Therefore, target gene expression may be influenced by the absolute and relative intranuclear stoichiometries of individual FBPs (Chung et al., 2006) . Binding of FBP to FUSE is essential for c-myc transcription. Moreover, inhibition or loss of FBP function arrests cellular proliferation and abrogates c-myc expression (He et al., 2000a; Chung and Levens, 2005) . Accordingly, we speculate that FBP proteins function as key regulators of the c-myc promoter. FBP proteins comprise three domains: an NH 2 -terminal domain containing one classical nuclear localization signal sequence, a central domain constituting four regularly spaced K-homology motifs and a COOH-terminal domain containing two to four repeats of a tyrosine-rich motif (Chung and Levens, 2005) . FBP binds through its four K-homology domains to FUSE of the c-myc promoter, leading to the upregulation of the c-Myc level (Wierstra and Alves, 2008) . FBP expression patterns are parallel to those of c-Myc. Both proteins are expressed in proliferating cells, but not in quiescent or differentiated cells. The protein binds directly to the p62, p80 and p89 subunits of TFIIH, and its C-terminal transactivation domain enhances the 3 0 -5 0 helicase activity of p89, which is essential for transcription. TFIIH is necessary for various steps during transcription open-complex formation, initiation and promoter clearance. By recruiting TFIIH, FBP may control the diverse inputs of other transcription factors into basal transcription machinery (Vindigni et al., 2001) .
During development and normal tissue homeostasis, unwanted or damaged cells are discarded by promoting apoptosis (Raff, 1998) . Apoptosis involves a complex series of cellular events in which the constituents of a doomed cell are dismantled and packaged into smaller bodies for easy removal by neighboring cells or macrophages (Krysko et al., 2006) . At the core of the death process is a family of cytosolic cysteine proteases, designated caspases, which display specificity for aspartic acid residues (Stennicke and Salvesen, 1999; Denault and Salvesen, 2002) . Stimuli from death receptor ligands, chemotherapeutic agents or cellular stress factors activate initiator caspases. Once stimulated, these initiators process and directly activate downstream executioner caspase-3 and -7, which cleave distinct intracellular proteins involved in promoting the apoptotic phenotype (Nicholson, 1999; Denault and Salvesen, 2002) . In mammalian cells, several of the identified substrates are involved in DNA metabolism, cytoskeletal scaffolding, cell cycle regulation, repair and housekeeping, signaling, and physiologic and pathologic amplification (Fischer et al., 2003; Lee et al., 2003; Timmer and Salvesen, 2007) .
Recent reports show that the c-Myc oncogene is involved in apoptosis, growth and proliferation. In particular, c-Myc induces apoptosis by triggering Bax oligomerization (Lalier et al., 2007; Cao et al., 2008) . Furthermore, c-Myc acts as a gatekeeper of the caspase feedback amplification loop (Nieminen et al., 2007) . Consequently, fine regulation of c-Myc may be important in determining the cell fate between apoptosis and growth. Earlier, we successfully identified novel caspase-3 and caspase-7 substrates using the degradomic approach (Lee et al., 2004; Jang et al., 2007) . Thiede et al. additionally reported that several proteins, including FBP-1, are modified in Jurkat T cells during apoptosis (Thiede et al., 2001) . Data from this study show that FBP-1 is cleaved by caspase-3 and -7, both in vitro and during apoptosis induced by various stimuli. Cleavage of FBP-1 during apoptosis leads to a decrease in its overall nuclear level and corresponding marked downregulation of c-myc expression. Our results provide valuable information on the fine regulation of c-Myc by caspase(s) during apoptosis.
Results

FBP-1 is a candidate substrate of caspases
Extracts from MCF-7 cells (500 mg) were incubated for 4 h with purified caspase-7 (20 U). The control sample was treated with caspase-7 and the inhibitor, z-DEVDfmk. Both samples were analysed using two-dimensional electrophoresis (Jang et al., 2007) . Among the proteins that were reproducibly altered, two prominent spots with molecular weights of B67 kDa disappeared, whereas two new spots migrating with apparently lower molecular weights and higher pI values appeared in samples treated with caspase-7 only (Figure 1a ). Spots 35 S-labeled proteins (5 ml) were incubated in 20 ml of caspase reaction buffer containing either active caspase-3 or caspase-7 at 37 1C for 1 h. Proteins were resolved by SDS-PAGE (10%) and detected by autoradiography. The cleaved fragment was detected (arrow). SDS-PAGE, SDS-polyacrylamide gel electrophoresis.
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M Jang et al were identified as FBP-1 with the aid of mass spectrometry analysis. Western blotting of MCF-7 cell extracts treated with caspase-7 (shown in Figure 1b ) confirmed FBP-1 cleavage.
In vitro cleavage assay of FBP-1 To confirm the validity of our approach, we determined whether recombinant FBP-1 is cleaved by purified caspase-7 in vitro. Recombinant trx-tagged FBP-1 and caspase-7 were incubated. As shown in Figure 1c , FBP-1 was cleaved by caspase-7. The presence of the B60-kDa fragment was confirmed by western blot analysis using an anti-FBP-1 antibody. Upon blockage of caspase activity with z-DEVD-fmk, cleavage of FBP-1 was nearly abrogated, clearly indicating that FBP-1 is a direct substrate of caspase-7. To validate the in vitro cleavage of FBP-1, we investigated whether the protein generated using the in vitro transcription and translation system is a substrate of caspase-3 or caspase-7. FBP-1 is cleaved in various cell lines during apoptosis Next, we examined whether endogenous FBP-1 is digested by endogenous caspase(s) during apoptosis. MCF-7, a caspase-3-deficient cell line, underwent apoptosis upon exposure to staurosporine (1 mM) for 24 h. Cells were harvested and subjected to western blot analysis with an anti-FBP-1 antibody. The well-known caspase substrate, PARP, was cleaved. In addition, the FBP-1 level was decreased significantly in a caspasedependent manner (Figure 2a ). However, cleaved FBP-1 in apoptotic MCF-7 was barely detected. The MCF-7 cell line does not possess caspase-3, and thus cleavage of FBP-1 in these cells during apoptosis is clearly dependent on caspase-7. FBP-1 was digested by caspases in HL-60 cells during apoptosis induced by etoposide ( Figure 2b ). HeLa cells were treated with tumor necrosis factor-a plus cycloheximide to induce apoptosis. In contrast to the data obtained with MCF-7, the cleaved FBP-1 fragment was clearly detected in apoptotic HL-60 cells ( Figure 2c ). Our results indicate that cleavage of FBP-1 during apoptosis is not dependent on the type of cell line or apoptotic stimulus. Next, we performed a time-course analysis of FBP-1 cleavage by caspase(s) during apoptosis. As shown in Figure 2d , caspasedependent cleavage of FBP-1 occurred before complete cleavage of PARP, an early event in apoptosis. However, the non-cleavable mutants (D74A), ND74 and N74, were not affected by TNFa plus CHX. NS represents nonspecific band. CHX, cycloheximide; TNFa, tumor necrosis factor-a.
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To ascertain the cleavage site of FBP-1 in vivo, several expression constructs, including D74A FBP-1, ND74 (FBP-1 lacking the N-terminal 74 amino acids) and N74 (FBP-1 N-terminal 74 amino acids), were generated and transfected into HeLa cells. Glutathione S-transferase (GST)-tagged wild-type FBP-1 was cleaved in apoptotic HeLa cells, whereas GST-tagged D74A FBP-1 was resistant to cleavage ( Figure 2e ). In addition, the ND74 and N74 levels were not significantly altered in apoptotic HeLa cells. Our results clearly suggest that DQPD 74 k is the principal cleavage site of caspase(s) during apoptosis.
c-Myc is downregulated in apoptotic cells through FBP-1 cleavage by caspase(s) In view of the finding that FBP-1 regulates c-myc expression by binding upstream of the promoter region, we examined the c-myc level during apoptosis in a timecourse experiment. As shown in Figure 2d , c-Myc expression was dramatically decreased during apoptosis in HL-60 cells, coincident with FBP-1 cleavage by caspases. Next, we examined whether FBP-2 and FBP-3 are caspase-7 substrates, using an in vitro cleavage assay. Interestingly, caspase-7 could not cleave either FBP-2 or FBP-3 (Supplementary Figure 1a) . The relative FBP levels during apoptosis were additionally measured. The c-myc level clearly correlated with the FBP-1 cleavage pattern, whereas the FBP-2 and FBP-3 levels decreased significantly after FBP-1 cleavage (Supplementary Figure 1b) . We speculate that FBP-2 and FBP-3 are digested in a caspase-independent manner. The decrease in FBP-2 and FBP-3 levels may also contribute to c-Myc downregulation during apoptosis.
Cleavage of FBP-1 and downregulation of c-myc expression occur at early time points of apoptosis, as depicted in Figures 2d and 3c . Moreover, the c-myc mRNA level was decreased during apoptosis in both MCF-7 and HL-60 cells (Figures 3a and b) . On the basis of these results, we suggest that FBP-1 is cleaved by caspases activated by apoptotic stimuli, and, in turn, promotes the downregulation of c-myc expression. Next, we assessed the expression of c-Myc downstream target genes during apoptosis using reverse transcriptase-PCR (Figure 3a ) and real-time PCR (Figure 3d) procedures. As expected, the levels of various target genes, including odc, cyclin A, cdk4 and cyclin D1, were reduced in apoptotic HL-60 cells.
The subcellular distribution of FBP-1 and effects of FBP-1 cleavage on cell viability The cleavage site of FBP-1 (DQPD 74 k) is located within the classical bipartite nuclear localization signal sequence of the N-terminal domain, with the caspase cleavage site located between both parts (He et al., 2000b) . Accordingly, we examined whether FBP-1 is translocated during apoptosis, using confocal microscopy. As shown in Figure 4a , FBP-1 was located in the nucleus in nearly 80% of resting cells, whereas about 20% of the cells contained FBP-1 in both the cytosol and nucleus. However, translocation of FBP-1 into the cytosol occurred after the application of apoptotic stimuli. Exclusive cytosolic localization was detected in approximately 30% of the cells following apoptotic treatment. Translocation of FBP-1 to the cytosol was suppressed upon treatment with a caspase inhibitor (Figures 4a and b) , signifying the involvement of active caspase(s) in this process. FBP-1 translocation into the cytosol during apoptosis is clearly depicted in Figure 4c . Active caspase-3 co-localized with FBP-1 in confocal microscopic analyses (Supplementary Figure 2) . Next, we examined the effects of FBP-1 cleavage and changes in subcellular redistribution on cell viability after the application of apoptotic stimuli to cells. As shown in Figure 5a , GST-tagged wild-type FBP-1 was detected in both the cytosol and nucleus. On the other hand, GSTtagged ND74 FBP-1 was exclusively localized in the cytosol. Our findings indicate that the N-terminal 74 residues of FBP-1 are necessary for protein targeting to the nucleus. A cell-viability assay following apoptotic stimulus application showed that D74A FBP-1 promotes increased cell viability, compared with wild-type FBP-1. ND74 and N74 FBP-1 induced no significant changes in cell viability upon apoptotic stimulation (Figure 5b) . Thus, it appears that cleaved FBP-1 products have no effects on cell proliferation and apoptosis, whereas increased viability, concomitant with an increased level of c-myc mRNA, is seen in D74A FBP-1-transfected cells (Figure 5c ). We confirmed that GST-tagged wild-type FBP-1 was cleaved during these experiments, whereas D74A FBP-1 was resistant to cleavage by caspase(s) by using a portion of the samples analysed in Figures 5b and c for a western blot analysis ( Supplementary Figures 3a and b) .
Discussion
The c-Myc protein responds to a number of intracellular and extracellular signals, including metabolic state, hormones, cytokines and various biological processes. Deregulation of c-myc expression is tumorigenic, promoting genomic instability (Chung and Levens, 2005; Wierstra and Alves, 2008) , and thus a tight control is essential in cells. FBPs regulate c-myc transcription through the general transcription factor, TFIIH (Wierstra and Alves, 2008) . In this study, we examine the possibility that FBP-1 is a valid caspase substrate. Our results clearly demonstrate that FBP-1 is a substrate of both caspase-7 and -3 during apoptosis. Moreover, FBP-1 cleaved by caspase(s) cannot translocate to the nucleus. The lower level of FBP-1 in the nucleus, in turn, leads to the downregulation of c-myc and a reduced expression of c-Myc downstream target genes. It seems likely that this is a key mechanism of abolishing cell proliferation and promoting apoptosis. However, there are a number of other FBP-1 target proteins that could be affected by its cleavage and that could contribute to its regulation of apoptosis.
The c-Myc protein has oncogenic potential and induces cell cycle progression (Chung and Levens, 2005) . However, this oncoprotein is also involved in the induction of apoptosis through a Bax-dependent mechanism and signal amplification through a process designated 'caspase feedback amplification loop' during apoptosis (Nieminen et al., 2007; Cao et al., 2008) . These earlier reports suggest that c-Myc sensitizes cells to apoptosis by promoting the activation of the mitochondrial apoptosis pathway. In addition, c-Mycdependent priming of the mitochondrial pathway is essential for activating the effector caspases and establishing a lethal caspase feedback amplification loop during the early stages of apoptosis. However, the mechanisms by which cells regulate the balance between the pro-apoptotic and antiapoptotic functions of c-Myc during apoptosis remain to be established. In conjunction with earlier reports, the present results suggest that marked downregulation of the c-Myc protein through FBP-1 cleavage by caspase(s) may function as a 'switchoff' mechanism, both in terms of the caspase feedback amplification loop and proliferation signal of c-Myc after the death decision (Figure 5d ). In other words, following apoptotic stress, (1) c-Myc participates in cell death as a pro-apoptotic factor (including involvement in Bax oligomerization and the caspase feedback amplification loop); and (2) Downregulation of c-Myc upon FBP-1 cleavage by caspases M Jang et al apoptosis appears to be the key message for eliciting the 'death' response as the ultimate cell fate.
Materials and methods
Cell cultures and induction of apoptosis
Human breast cancer epithelial MCF-7 and malignant epithelial HeLa cells were cultured in Dulbecco's modified essential medium supplemented with 10% heat-inactivated fetal bovine serum, penicillin (100 U ml
À1
) and streptomycin (100 mg ml
). Human promyelocytic leukemia HL-60 cells were cultured in RPMI. Apoptosis was induced by treatment with 1 mM staurosporine, 100 mM etoposide or 10 ng ml À1 tumor necrosis factor-a plus 1 mg ml À1 cycloheximide for the indicated times.
Site-directed mutagenesis and protein purification For recombinant caspase-3 and -7 protein purification, cDNAs were subcloned into the pET21a ( þ ) vector and purified, as described earlier (Lee et al., 2004; Jang et al., 2007) . For expression in HeLa cells, FBP-1 cDNA was subcloned into pET32a ( þ ) and pEBG encoding a GST tag. The QuikChange Multi-Site-Directed Mutagenesis Kit was employed to mutate the caspase cleavage site (D74A), according to the manufacturer's instructions (Stratagene, La Jolla, CA, USA), using the primers 5 0 -GGAGATCAACCAGCTGCTAAGAAAG-3 0 and 5 0 -CTTTCTTAGCAGCTGGTTGATCTCC-3 0 . FBP-1 lacking the N-terminal 74 amino acids (ND74 FBP-1) was obtained using the primers (5 0 -GAGCTCGCTAAGAAAGTTGCTC CTC-3 0 and 5 0 -ATTTGCGGCCGCCTACAGAGCTAGTTC TATAC-3 0 , underlines indicate the restriction enzyme sites.), and inserted into pEBG. The N terminus of FBP-1 (N74) was obtained by PCR using the primers (5 0 -CGCGGATCCA TGGCAGACTATTCAACAG-3 0 and 5 0 -ATTTGCGGCCGC CTAATCTGGTTGATCTCCAT-3 0 , underlines indicate the restriction enzyme sites), and inserted into the pEBG vector. His 6 -tagged recombinant proteins were expressed in Escherichia coli BL21 DE3 (RIL), induced with IPTG at 37 1C and purified using Ni-NTA chelating agarose CL-6B, according to the manufacturer's instructions (Peptron, Daejeon, Korea). Purified caspase activity was monitored by measuring pnitroanilide generated by cleavage of Ac-DEVD-p-nitroanilide (Calbiochem, San Diego, CA, USA) with active caspase. Immunofluorescence staining Cells were seeded in six-well plates and cultured in Dulbecco's modified essential medium, fixed for 15 min at room temperature with BD Cytofix/Cytoperm (BD Biosciences), and treated with the Image-iT FX signal enhancer (Invitrogen, Carlsbad, CA, USA) for 30 min. Following blockage with 3% bovine serum albumin in phosphate-buffered saline for 10 min, cells were incubated with primary antibody overnight at 4 1C and secondary antibody at room temperature for 1 h. The primary antibodies, anti-FBP-1 (recognizes the region after residue 74 of FBP-1; sc-33030, Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) and anti-GST (1:50 dilution), and the secondary antibodies, Alexa Fluor 546-labeled rabbit immunoglobulin G and Alexa Fluor 546-labeled goat immunoglobulin G (Molecular Probes, Eugene, OR, USA) (1:100 dilution), were employed. Confocal imaging was performed using LSM 510 META (ZEISS).
Reverse transcriptase-PCR Total RNA was prepared from MCF-7 and HL-60 cells using an RNA Isolation kit (PARIS) (Ambion, Austin, TX, USA), following the manufacturer's instructions. cDNA was synthesized from 1 mg of total RNA with the RevertAid H Minus First Strand cDNA Synthesis Kit (Fermentas Life Sciences, Glen Burnie, MD, USA). Reverse transcriptase-PCR was performed, as described earlier (Jang et al., 2007) . Briefly, samples were denatured at 95 1C for 30 s, followed by 25 cycles of 95 1C for 30 s, 55 1C for 30 s and 72 1C for 30 s. The last cycle was followed by an additional extension step of 72 1C for 10 min. Products were analysed on a 1% agarose gel containing 0.2 mg ml À1 ethidium bromide and visualized under an ultraviolet transilluminator. Densitometric analysis of PCR products was performed with computer software and standardized to the actin product.
For real-time PCR, SYBR Premix Ex Tag (TaKaRa) was employed. The following primers were used for gene amplification: c-myc, Released cytochrome c associates with APAF-1 and procaspase-9 to form the apoptosome. Caspase-9 activity is stimulated, leading to the activation of effector caspase-3 and -7, and ultimately, the execution phase of the apoptosis pathway. In addition, activated effector caspases cleave FBP-1. Cleaved FBP-1 cannot be introduced into the nucleus, resulting in a marked downregulation of c-Myc and downstream target proteins. Therefore, both the pro-apoptotic function during the early phases of apoptosis and antiapoptotic function (growth/proliferation signal) of c-Myc are suppressed after the successful initiation of cell death. CHX, cycloheximide; TNFa, tumor necrosis factor-a. and 5 0 -GCCCAATCAGGTCAAAGATT-3 0 ; and b-actin, 5 0 -AGGCCCAGAGCAAGAGAGG-3 0 and 5 0 -TACATGGC TGGGGTGTTGAA-3 0 . Statistical analysis was performed using an independent Student's t-test, and a P-value of o0.05 was considered statistically significant.
Cell viability assay
Cell viability was quantified with the CCK-8 assay, following the manufacturer's instructions. Briefly, cells were seeded in six-well plates, cultured in Dulbecco's modified essential medium and transfected with pEBG, GST-FBP1, GST-D74A FBP1, GST-ND74 or GST-N74. After 48 h, transfected HeLa cells were added to a 96-well microplate and incubated for 24 h. Next, cells were treated with tumor necrosis factor-a plus cycloheximide from 12 to 48 h, and 10 ml of CCK-8 reagent was added to each well. Plates were incubated for 2 h at 37 1C, and the difference in absorbance at 450 nm was measured as an indicator of cell viability.
